treatment

An extract from a rare undersea creature will soon be put to the test in clinical trials after initial studies showed effectiveness in stopping COVID-19 infections, according to a pharmaceutical company and a California-based researcher who has been studying it.

The most comprehensive national study to date has found that convalescent plasma appears to be safe to use on COVID-19 patients, a promising development in the race to find a treatment for the deadly virus. But the study didn’t determine whether the treatment works, NBC News reported. A team of more than 5,000 doctors from over 2,000 hospitals and laboratories…

Gilead Sciences said that a draft document showing disappointing results from a closely watched clinical trial of the company’s treatment for the coronavirus contained “inappropriate characterizations” and that the study’s findings were “inconclusive.”

Trinity Health of New England, the health system that runs Saint Francis Hospital in Hartford, has treated its first patient with donated blood plasma in its COVID-19 clinical trial. The health system began collecting plasma from donors this week, and administered the plasma to the first patient on Wednesday. The concept of the blood plasma treatment involves collecting plasma that…

Using methods developed by the Mayo Clinic, UConn Health officials are hopeful antibodies developed by recovered patients could help others survive.

Using protocol developed by the Mayo Clinic, blood plasma of recovered COVID-19 patients will be collected by the American Red Cross. It will be processed, then turned over to UConn Health where it will be administered to UConn Health patients